Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05770765

Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases

This is the protocol that formalizes the establishment of the TROPICA-BIOBANK biobank

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Sacro Cuore Don Calabria hospital

Negrar, Verona, 37024, Italy

Location status: Recruiting

Location contact

Dora Buonfrate

CONTACT

[email protected]

Dora Buonfrate

SUB_INVESTIGATOR

Zeno Bisoffi

PRINCIPAL_INVESTIGATOR

About this study

Subjects who will access the Department of Infectious and Tropical Diseases for investigations, analyzes or visits on suspicion of infectious or tropical disease, hospitalized patients and/or patients participating in proposed clinical trials from the Department will be enrolled. Healthy volunteer donors may also be enrolled.

The type of samples collected and stored in the biobank consists of human biological matrices liquids and solids, DNA, protein extracts or subcellular fractions, bacterial isolates and arthropods taken from patients. The collection of samples takes place through the support of various professional figures (doctor, nurse, laboratory technician, biologist/biotechnologist) together with associated data.

The samples are de-identified and protected by an encryption system (through the system computer diagnostic data management of the laboratory of the IRCCS Sacro Cuore Don Calabria) and stored at a temperature of -80°C, in the Department's freezers. Samples are stored for 40 years. In order to monitor the quality of the samples over the storage time, a selection of samples used as monthly analytical quality controls will be retested periodically (every 10 years). At the end of the storage time, it will be evaluated whether to extend the storage time of the unused biological samples and associated data or if these will be destroyed. In the first case, an amendment to this Protocol will be submitted to the CESC for approval, in which will specify the duration of the extension of the conservation of the samples and associated data. In the second case, no further data will be collected on the aforementioned samples, without prejudice to their use of those possibly already collected to determine, without altering them, the results of searches already in progress.

The samples will in any case be destroyed if they are not in good condition.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed consent (for healthy volounteers also: age > 18 years, health status ascertained by laboratory tests, electrocardiogram and medical examination)

Exclusion criteria

  • History of alcohol/drug abuse
  • Pregnant or breastfeeding women, unless there are justified and documented needs

Treatment and study plan

Primary outcomes

  1. Presence of a viral, bacterial or parasitic pathogen

    Time frame: 40 years

    Result of laboratory tests on the pathogen responsible for the disease of interest

Study contacts

Contact information is provided by the study sponsor or research team.

Elvia Malo

CONTACT

[email protected]

+390456014854

Sponsors and collaborators

Lead sponsor

IRCCS Sacro Cuore Don Calabria di Negrar

Other

Registry information

Acronym: TropicaBiobank

Important dates

Study start
2019
Primary completion
2059
Study completion
2059
First posted
Mar 15, 2023
Registry last updated
Mar 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.